Bruce Keyt
2019
In 2019, Bruce Keyt earned a total compensation of $601.5K as Chief Scientific Officer at IGM Biosciences, a 71% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $151,743 |
|---|---|
| Option Awards | $92,714 |
| Salary | $357,000 |
| Total | $601,457 |
Keyt received $357K in salary, accounting for 59% of the total pay in 2019.
Keyt also received $151.7K in non-equity incentive plan and $92.7K in option awards.
Rankings
In 2019, Bruce Keyt's compensation ranked 11,195th out of 13,971 executives tracked by ExecPay. In other words, Keyt earned more than 19.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,195 out of 13,971 | 20th |
Division Manufacturing | 4,531 out of 5,698 | 21st |
Major group Chemicals And Allied Products | 1,780 out of 2,197 | 19th |
Industry group Drugs | 1,532 out of 1,883 | 19th |
Industry Pharmaceutical Preparations | 1,133 out of 1,395 | 19th |
Source: SEC filing on July 6, 2020.
Keyt's colleagues
We found two more compensation records of executives who worked with Bruce Keyt at IGM Biosciences in 2019.
News
IGM Biosciences CEO Fred Schwarzer's 2022 pay falls 46% to $5.3M
April 27, 2023
IGM Biosciences CEO Fred Schwarzer's 2021 pay jumps 94% to $9.9M
April 27, 2022
IGM Biosciences CEO Fred Schwarzer's 2020 pay jumps 574% to $5.1M
April 29, 2021
IGM Biosciences CEO Fred Schwarzer's 2019 pay jumps 46% to $757K
April 21, 2020